Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Hepatic cell-type specific gene expression better predicts HCV treatment outcome than IL28B genotype.

    McGilvray I, Feld JJ, Chen L, Pattullo V, Guindi M, Fischer S, Borozan I, Xie G, Selzner N, Heathcote EJ, Siminovitch K.

    Gastroenterology. 2012 May;142(5):1122-1131.e1. Epub 2012 Jan 25.

    PMID:
    22285807
    [PubMed - in process]
    2.

    Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon.

    Levitsky J, Fiel MI, Norvell JP, Wang E, Watt KD, Curry MP, Tewani S, McCashland TM, Hoteit MA, Shaked A, Saab S, Chi AC, Tien A, Schiano TD.

    Gastroenterology. 2012 May;142(5):1132-1139.e1. Epub 2012 Jan 25.

    PMID:
    22285805
    [PubMed - in process]
    3.

    Is HCV infection a neurologic disorder?

    Féray C.

    Gastroenterology. 2012 Mar;142(3):428-31. Epub 2012 Jan 25. No abstract available.

    PMID:
    22285362
    [PubMed - indexed for MEDLINE]
    4.

    HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.

    Thomas E, Gonzalez VD, Li Q, Modi AA, Chen W, Noureddin M, Rotman Y, Liang TJ.

    Gastroenterology. 2012 Apr;142(4):978-88. Epub 2012 Jan 13.

    PMID:
    22248663
    [PubMed - indexed for MEDLINE]
    5.

    Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis C.

    Chu TW, Kulkarni R, Gane EJ, Roberts SK, Stedman C, Angus PW, Ritchie B, Lu XY, Ipe D, Lopatin U, Germer S, Iglesias VA, Elston R, Smith PF, Shulman NS.

    Gastroenterology. 2012 Apr;142(4):790-5. Epub 2012 Jan 13.

    PMID:
    22248659
    [PubMed - indexed for MEDLINE]
    6.

    Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.

    Beinhardt S, Aberle JH, Strasser M, Dulic-Lakovic E, Maieron A, Kreil A, Rutter K, Staettermayer AF, Datz C, Scherzer TM, Strassl R, Bischof M, Stauber R, Bodlaj G, Laferl H, Holzmann H, Steindl-Munda P, Ferenci P, Hofer H.

    Gastroenterology. 2012 Jan;142(1):78-85.e2. Epub 2011 Sep 24.

    PMID:
    22192885
    [PubMed - indexed for MEDLINE]
    7.

    A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses.

    Polyak SJ, Morishima C, Scott JD, Gastaminza P, Cox A, de Araújo ES, Higgs MR, Loo YM, Golden-Mason L, Lindenbach BD, Baumert TF, Randall G, Gale M Jr.

    Gastroenterology. 2012 Jan;142(1):e1-5. No abstract available. Erratum in: Gastroenterology. 2012 Feb;142(2):411. Gastaminza, Pablo [added].

    PMID:
    22185796
    [PubMed - indexed for MEDLINE]
    8.

    Autophagy protects cells from HCV-induced defects in lipid metabolism.

    Vescovo T, Romagnoli A, Perdomo AB, Corazzari M, Ciccosanti F, Alonzi T, Nardacci R, Ippolito G, Tripodi M, Garcia-Monzon C, Lo Iacono O, Piacentini M, Fimia GM.

    Gastroenterology. 2012 Mar;142(3):644-653.e3. Epub 2011 Dec 7.

    PMID:
    22155365
    [PubMed - indexed for MEDLINE]
    9.

    Peptidomimetic escape mechanisms arise via genetic diversity in the ligand-binding site of the hepatitis C virus NS3/4A serine protease.

    Welsch C, Shimakami T, Hartmann C, Yang Y, Domingues FS, Lengauer T, Zeuzem S, Lemon SM.

    Gastroenterology. 2012 Mar;142(3):654-63. Epub 2011 Dec 7.

    PMID:
    22155364
    [PubMed - indexed for MEDLINE]
    10.

    Hepatitis C virus infects the endothelial cells of the blood-brain barrier.

    Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA.

    Gastroenterology. 2012 Mar;142(3):634-643.e6. Epub 2011 Dec 1.

    PMID:
    22138189
    [PubMed - indexed for MEDLINE]
    11.

    Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B.

    Sonneveld MJ, Wong VW, Woltman AM, Wong GL, Cakaloglu Y, Zeuzem S, Buster EH, Uitterlinden AG, Hansen BE, Chan HL, Janssen HL.

    Gastroenterology. 2012 Mar;142(3):513-520.e1. Epub 2011 Nov 19.

    PMID:
    22108195
    [PubMed - indexed for MEDLINE]
    12.

    CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis.

    Nakamoto N, Ebinuma H, Kanai T, Chu PS, Ono Y, Mikami Y, Ojiro K, Lipp M, Love PE, Saito H, Hibi T.

    Gastroenterology. 2012 Feb;142(2):366-76. Epub 2011 Nov 10.

    PMID:
    22079594
    [PubMed - indexed for MEDLINE]
    13.

    Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks.

    Sarrazin C, Schwendy S, Möller B, Dikopoulos N, Buggisch P, Encke J, Teuber G, Goeser T, Thimme R, Klinker H, Boecher WO, Schulte-Frohlinde E, Prinzing R, Herrmann E, Zeuzem S, Berg T.

    Gastroenterology. 2011 Nov;141(5):1656-64. Epub 2011 Jul 22.

    PMID:
    21784046
    [PubMed - indexed for MEDLINE]
    14.

    Interferon-free treatment regimens for hepatitis C: are we there yet?

    Sharma P, Lok AS.

    Gastroenterology. 2011 Dec;141(6):1963-7. Epub 2011 Oct 25. No abstract available.

    PMID:
    22033188
    [PubMed - indexed for MEDLINE]
    15.

    Treatment of chronic hepatitis delta: mission impossible?

    Romeo R, Colombo M.

    Gastroenterology. 2011 Dec;141(6):2268-71. Epub 2011 Oct 25. No abstract available.

    PMID:
    22033187
    [PubMed]
    16.

    Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.

    Deugnier Y, Turlin B, Ropert M, Cappellini MD, Porter JB, Giannone V, Zhang Y, Griffel L, Brissot P.

    Gastroenterology. 2011 Oct;141(4):1202-11, 1211.e1-3. Epub 2011 Jul 7. Erratum in: Gastroenterology. 2012 Jan;142(1):186.

    PMID:
    21741344
    [PubMed - indexed for MEDLINE]
    17.

    Targeting unlesioned pharyngeal motor cortex improves swallowing in healthy individuals and after dysphagic stroke.

    Michou E, Mistry S, Jefferson S, Singh S, Rothwell J, Hamdy S.

    Gastroenterology. 2012 Jan;142(1):29-38. Epub 2011 Sep 29.

    PMID:
    21963761
    [PubMed - indexed for MEDLINE]
    18.

    Error occurred: cannot get document summary

    PMID:
    21946415

    19.

    Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection.

    Zeuzem S, Asselah T, Angus P, Zarski JP, Larrey D, Müllhaupt B, Gane E, Schuchmann M, Lohse A, Pol S, Bronowicki JP, Roberts S, Arasteh K, Zoulim F, Heim M, Stern JO, Kukolj G, Nehmiz G, Haefner C, Boecher WO.

    Gastroenterology. 2011 Dec;141(6):2047-55; quiz e14. Epub 2011 Sep 16.

    PMID:
    21925126
    [PubMed - indexed for MEDLINE]
    20.

    A view to natural killer cells in hepatitis C.

    Shoukry NH, Pelletier S, Chang KM.

    Gastroenterology. 2011 Oct;141(4):1144-8. Epub 2011 Aug 27. No abstract available.

    PMID:
    21875586
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk